参考文献

2020-10-20

1: Larif S, Slim R, Fathallah N, Ghariani N, Hmouda H, Salem CB.
Lornoxicam-induced acute generalized exanthematous pustulosis. Int J Dermatol.
2016 Mar 11. doi: 10.1111/ijd.13252. [Epub ahead of print] PubMed PMID: 26971725.

2: Çelik H, Abdullayev R, Akçaboy EY, Baydar M, Göğüş N. [Comparison of tramadol
and lornoxicam in intravenous regional anesthesia: a randomized controlled
trial]. Rev Bras Anestesiol. 2016 Jan-Feb;66(1):44-9. doi:
10.1016/j.bjan.2015.11.003. Epub 2015 Nov 29. Portuguese. PubMed PMID: 26647089.

3: Çelik H, Abdullayev R, Akçaboy EY, Baydar M, Göğüş N. Comparison of tramadol
and lornoxicam in intravenous regional anesthesia: a randomized controlled trial.
Braz J Anesthesiol. 2016 Jan-Feb;66(1):44-9. doi: 10.1016/j.bjane.2014.07.013.
Epub 2015 Mar 29. PubMed PMID: 26768929.

4: Salama AH, Shamma RN. Tri/tetra-block co-polymeric nanocarriers as a potential
ocular delivery system of lornoxicam: in-vitro characterization, and in-vivo
estimation of corneal permeation. Int J Pharm. 2015 Aug 15;492(1-2):28-39. doi:
10.1016/j.ijpharm.2015.07.010. Epub 2015 Jul 4. PubMed PMID: 26151106.

5: Gorsky VA, Agapov MA, Khoreva MV, Leonenko IV. The effect of lornoxicam on
TLR2 and TLR4 messenger RNA expression and tumor necrosis factor-α,
interleukin-6, and interleukin-8 secretion in patients with systemic
complications of acute pancreatitis. Pancreas. 2015 Jul;44(5):824-30. doi:
10.1097/MPA.0000000000000344. PubMed PMID: 25872171.

6: Patel JC, Patel PB, Acharya H, Nakum K, Tripathi CB. Efficacy and safety of
lornoxicam vs ibuprofen in primary dysmenorrhea: a randomized, double-blind,
double dummy, active-controlled, cross over study. Eur J Obstet Gynecol Reprod
Biol. 2015 May;188:118-23. doi: 10.1016/j.ejogrb.2015.03.005. Epub 2015 Mar 9.
PubMed PMID: 25808572.

7: Abdel-Ghaffar HS, Abdel-Azeem HG, Roushdy MM. Safety and efficacy of
pre-incisional peritonsillar lornoxicam in paediatric post-tonsillectomy pain: a
prospective double-blind, placebo-controlled, split-body clinical study. Clin
Otolaryngol. 2015 Jun;40(3):219-26. doi: 10.1111/coa.12351. PubMed PMID:
25404551.

8: Anumolu PD, Sunitha G, Bindu SH, Satheshbabu PR, Subrahmanyam CV. Development
and Validation of Discriminating and Biorelevant Dissolution Test for Lornoxicam
Tablets. Indian J Pharm Sci. 2015 May-Jun;77(3):312-20. PubMed PMID: 26180277;
PubMed Central PMCID: PMC4502146.

9: Kotsovolis G, Karakoulas K, Grosomanidis V, Tziris N. Comparison between the
combination of gabapentin, ketamine, lornoxicam, and local ropivacaine and each
of these drugs alone for pain after laparoscopic cholecystectomy: a randomized
trial. Pain Pract. 2015 Apr;15(4):355-63. doi: 10.1111/papr.12183. Epub 2014 Feb
27. PubMed PMID: 24571062.

10: Gönüllü Ü, Üner M, Yener G, Karaman EF, Aydoğmuş Z. Formulation and
characterization of solid lipid nanoparticles, nanostructured lipid carriers and
nanoemulsion of lornoxicam for transdermal delivery. Acta Pharm. 2015
Mar;65(1):1-13. doi: 10.1515/acph-2015-0009. PubMed PMID: 25781700.

11: Alharbi MB. Lornoxicam Side Effects May Lead to Surgical Mismanagement, in
Case of Postoperative Intra-Abdominal Collection: A Case Report and Literature
Review. Case Rep Surg. 2015;2015:545807. doi: 10.1155/2015/545807. Epub 2015 Aug
31. PubMed PMID: 26417471; PubMed Central PMCID: PMC4568387.

12: Kilbaş Z, Menteş MÖ, Harlak A, Yiğit T, Balkan SM, Coşar A, Öztürk E, Kozak
O, Tufan CT. Efficacy of wound infiltration with lornoxicam for postoperative
analgesia following thyroidectomy: a prospective, randomized, double-blind study.
Turk J Med Sci. 2015;45(3):700-5. PubMed PMID: 26281342.

13: Hadi MA, Rao NG, Rao AS. Formulation and evaluation of
mini-tablets-filled-pulsincap delivery of lornoxicam in the chronotherapeutic
treatment of rheumatoid arthritis. Pak J Pharm Sci. 2015 Jan;28(1):185-93. PubMed
PMID: 25553695.

14: Abdelbary GA, Aburahma MH. Oro-dental mucoadhesive proniosomal gel
formulation loaded with lornoxicam for management of dental pain. J Liposome Res.
2015;25(2):107-21. doi: 10.3109/08982104.2014.941861. Epub 2014 Jul 24. PubMed
PMID: 25058447.

15: Li F, Song S, Guo Y, Zhao Q, Zhang X, Pan W, Yang X. Preparation and
pharmacokinetics evaluation of oral self-emulsifying system for poorly
water-soluble drug Lornoxicam. Drug Deliv. 2015;22(4):487-98. doi:
10.3109/10717544.2014.885615. Epub 2014 Feb 13. PubMed PMID: 24524289.

16: Sun HL, Dong YC, Wang CQ, Qian YN, Wang ZY. Effects of postoperative
analgesia with the combination of tramadol and lornoxicam on serum inflammatory
cytokines in patients with gastric cancer. Int J Clin Pharmacol Ther. 2014
Dec;52(12):1023-9. doi: 10.5414/CP202190. PubMed PMID: 25295719.

17: Gorskii VA, Agapov MA, Khoreva MV, Petrov VA, Kravchenko AY, Battaev AI.
Effect of lornoxicam therapy on expression of TLR2 and TLR4 mRNA during systemic
complications of acute pancreatitis. Bull Exp Biol Med. 2014 Nov;158(1):13-5.
doi: 10.1007/s10517-014-2680-0. Epub 2014 Nov 19. PubMed PMID: 25403387.

18: Işik B, Yaman S, Aktuna S, Turan A. Analgesic efficacy of prophylactic
gabapentin and lornoxicam in preventing postendodontic pain. Pain Med. 2014
Dec;15(12):2150-5. doi: 10.1111/pme.12536. Epub 2014 Aug 19. PubMed PMID:
25138784.

19: Nijhawan M, Santhosh A, Babu PR, Subrahmanyam CV. Solid state manipulation of
lornoxicam for cocrystals--physicochemical characterization. Drug Dev Ind Pharm.
2014 Sep;40(9):1163-72. doi: 10.3109/03639045.2013.804834. Epub 2013 Jul 5.
PubMed PMID: 23829186.

20: Tawfeek HM, Saleem IY, Roberts M. Dissolution enhancement and formulation of
rapid-release lornoxicam mini-tablets. J Pharm Sci. 2014 Aug;103(8):2470-83. doi:
10.1002/jps.24073. Epub 2014 Jul 3. PubMed PMID: 24995853.